Article Details

Addition of Ipatasertib Confers No Benefit in Advanced Triple-Negative Breast Cancer

Retrieved on: 2020-12-11 00:22:30

Tags for this article:

Click the tags to see associated articles and topics

Addition of Ipatasertib Confers No Benefit in Advanced Triple-Negative Breast Cancer. View article details on hiswai:

Excerpt

The trial was sponsored by <b>Roche</b>/Genentech. For a full list of disclosures, please refer to the presentation slides. Read more of Cancer Therapy Advisor' ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up